Clinical Trial Detail

NCT ID NCT01834248
Title DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

acute myeloid leukemia

bone marrow cancer

Therapies

Decitabine + Rasdegafusp alfa

Age Groups: adult

No variant requirements are available.